Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd./ JP3463000004 /
TKPHF
|
07/11/2024 15:30:00
|
Chg.
-
|
Volume |
Bid- |
Ask- |
Market Capitalization |
Dividend Y. |
P/E Ratio |
|
26.7600USD
|
-
|
119,689
Turnover: 7,599.8400 |
-Bid Size: - |
-Ask Size: - |
43.41 bill.USD |
- |
- |
Business description
Located in Osaka, Japan, Takeda (TYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.
Management board & Supervisory board
| CEO |
| Christophe Weber |
| Management board |
| Costa Saroukos, Akiko Amakawa, Elaine Shannon, Gabriele Ricci, Giles Platford, Julie Kim, Lauren Duprey, Marcello Agosti, Milano Furuta, Mwana Lugogo, Ramona Sequeira, Takako Ohyabu, Teresa Bitetti, Thomas Wozniewski, Yoshihiro Nakagawa |
| Supervisory board |
| Christophe Weber, Costa Saroukos, Dr. Andrew Plump, Emiko Higashi, Ian Clark, Jean-Luc Butel, Koji Hatsukawa, Michel Orsinger, Olivier Bohuon, Yoshiaki Fujimori, Masami Iijima, Steven Gillis, John Maraganore, Miki Tsusaka, Kimberly A. Reed |
Company data
| Name: |
Takeda Pharmaceutical Company Ltd. |
| Address: |
1-1, Nihonbashi-Honcho 2-Chome,Chuo-ku, Tokyo 103-8668, Japan |
| Phone: |
+81-3-3278-2306 |
| Fax: |
+81-3-3278-2268 |
| E-mail: |
-
|
| Internet: |
www.takeda.com/ |
| Industry: |
Healthcare |
| Sector: |
Pharmaceutical Industry |
| Sub sector: |
Pharmaceuticals |
| End of financial year: |
31/03 |
| Free Float: |
- |
| IPO date: |
- |
